University of Edinburgh Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
University of Reading Featured PhD Programmes
"screening"×
10 miles

Pharmacology / Toxicology (screening) PhD Projects, Programs & Scholarships

We have 16 Pharmacology / Toxicology (screening) PhD Projects, Programs & Scholarships

  • "screening" ×
  • Pharmacology / Toxicology×
  • clear all
Order by 
Showing 1 to 10 of 16
  Development of an inhalable anti-tubercular therapies to include pre-clinical screening and 3D printing/additive manufacturing.
  Prof S Cryan, Prof A Heise, Dr J Keane
Application Deadline: 2 December 2019

Funding Type

PhD Type

Mycobacterium tuberculosis (TB) is the primary infectious disease killer in the world. In 2016 alone 1.7million people died from TB and 10 million people fell ill [1].
  Eastbio PhD Programme: Targeting the MYCBP2 E3 ubiquitin ligase with small molecules
  Prof A Ciulli, Dr S Virdee
Application Deadline: 5 January 2020

Funding Type

PhD Type

This 4 year PhD project is part of a competition funded by EASTBIO BBSRC Doctoral Training Partnership http://www.eastscotbiodtp.ac.uk/how-apply-0.
  Disrupting the regulatory mechanisms that allow hospital acquired infections to resist antibiotic therapy.
  Dr R McCarthy
Applications accepted all year round

Funding Type

PhD Type

The discovery of penicillin over 90 years ago and its subsequent uptake by healthcare systems around the world revolutionised global health and wellbeing.
  MRC DiMeN Doctoral Training Partnership: Drug discovery to control C. difficile infections by targeting sporulation
  Dr P Salgado, Dr J Hubbard
Application Deadline: 6 January 2020

Funding Type

PhD Type

Interested in a PhD studying antibiotic resistant bacteria and explore new ways to treat drug-resistant infections? In this PhD, you will use a range of biochemistry, biophysical and structural techniques, together with molecular biology, genetics, and microbiology approached to develop new therapeutics targeting C.
  (BBSRC DTP CASE) Exploitation of P450 BM3 variants for production of valuable drug metabolites
  Prof A Munro, Prof D Leys
Application Deadline: 31 January 2020

Funding Type

PhD Type

The US Food and Drug Administration (FDA) have recommended that human drug metabolites (as well as their parent drugs) should be subject to testing for safety/toxicity.
  Development of a three dimensional in vitro model of the human cornea to dissect the inflammatory events associated with sight-threatening ocular pathogens
  Dr C Dobson, Dr C Maldonado-Codina, Prof P Morgan
Applications accepted all year round

Funding Type

PhD Type

The presence of microbes at the corneal surface may trigger low grade discomfort through to acute eye infection and permanent loss of vision.
  How does a new antimicrobial kill the fungi that invade immunosuppressed patients?
  Prof T Levine
Application Deadline: 24 January 2020

Funding Type

PhD Type

Hard-to-treat fungal infections are a growing problem both UK and worldwide (rates respectively 10,000 and 2M/year; mortality 40% and 25%).
  Novel chemistry to protect the wheat crop
  Dr G Kettles
Application Deadline: 6 January 2020

Funding Type

PhD Type

Plant pathogens pose major challenges to crop production and food security. How we protect plants from their most damaging pathogens is therefore vital to a future of sustainable agriculture.
  Molecular mechanism of innate immunity mediated by the Toll/IL1 receptor signalling pathways.
  Prof N J Gay
Applications accepted all year round

Funding Type

PhD Type

This group participates in the Wellcome Trust 4 year PhD programme in Developmental biology., MRC and BBSRC Doctoral Training Programmes.
  P2X receptors in the peripheral nervous system: molecular pharmacology (FOUNTAINSU20SF)
  Dr S Fountain
Application Deadline: 31 May 2020

Funding Type

PhD Type

P2X receptors are ligand-gated ion channels activated by extracellular adenosine 5’-triphosphate (ATP). In the peripheral nervous system (PNS), ATP is a neurotransmitter acting in both autonomic and sensory nerve control of body tissue function and homeostasis.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.